The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Amneal Pharmaceuticals Inc shares valued at $372,481 were sold by Shah Nikita on May 16 ’25. At $7.58 per share, Shah Nikita sold 49,140 shares. The insider’s holdings dropped to 388,929 shares worth approximately $2.8 million following the completion of this transaction.
Also, Shah Nikita purchased 49,140 shares, netting a total of over 368,550 in proceeds.
Before that, Kiely John had sold 50,000 shares from its account. In a trade valued at $379,500, the Director traded Amneal Pharmaceuticals Inc shares for $7.59 each. Upon closing the transaction, the insider’s holdings decreased to 50,000 shares, worth approximately $1.85 million.
As published in a research note from JP Morgan on February 24, 2025, Amneal Pharmaceuticals Inc [AMRX] has been rated up from a Neutral to an Overweight and the price target has been revised to $12 from $9. Analysts at JP Morgan upgraded the stock from ‘”an Underweight”‘ to ‘”a Neutral”‘ outlook in a report released in early September. Earlier on March 08, 2021, Goldman upgraded its rating. Their new recommendation was “a Buy” for AMRX stock which previously was a “a Sell”.
Analyzing AMRX Stock Performance
During the last five days, there has been a drop of approximately -4.13%. Over the course of the year, Amneal Pharmaceuticals Inc shares have dropped approximately -9.22%. Shares of the company reached a 52-week high of $9.16 on 03/03/25 and a 52-week low of $6.68 on 04/10/25.
Support And Resistance Levels for Amneal Pharmaceuticals Inc (AMRX)
According to the 24-hour chart, there is a support level at 7.12, which, if violated, would cause prices to drop to 7.05. In the upper region, resistance lies at 7.28. The next price resistance is at 7.37. RSI (Relative Strength Index) is 41.72 on the 14-day chart, showing neutral technical sentiment.
